Cargando…
Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model
The long-term prognosis after resection of hepatocellular carcinoma (HCC), which is one of the treatment options for early-stage HCC, remains unsatisfactory as a result of a high incidence of disease recurrence. Recent studies performed in murine models revealed a link between liver regeneration und...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826248/ https://www.ncbi.nlm.nih.gov/pubmed/26695439 http://dx.doi.org/10.18632/oncotarget.6638 |